146 related articles for article (PubMed ID: 23688585)
1. iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein-protein interactions.
Labbé CM; Laconde G; Kuenemann MA; Villoutreix BO; Sperandio O
Drug Discov Today; 2013 Oct; 18(19-20):958-68. PubMed ID: 23688585
[TBL] [Abstract][Full Text] [Related]
2. iPPI-DB: an online database of modulators of protein-protein interactions.
Labbé CM; Kuenemann MA; Zarzycka B; Vriend G; Nicolaes GA; Lagorce D; Miteva MA; Villoutreix BO; Sperandio O
Nucleic Acids Res; 2016 Jan; 44(D1):D542-7. PubMed ID: 26432833
[TBL] [Abstract][Full Text] [Related]
3. Which three-dimensional characteristics make efficient inhibitors of protein-protein interactions?
Kuenemann MA; Bourbon LM; Labbé CM; Villoutreix BO; Sperandio O
J Chem Inf Model; 2014 Nov; 54(11):3067-79. PubMed ID: 25285479
[TBL] [Abstract][Full Text] [Related]
4. The iPPI-DB initiative: a community-centered database of protein-protein interaction modulators.
Torchet R; Druart K; Ruano LC; Moine-Franel A; Borges H; Doppelt-Azeroual O; Brancotte B; Mareuil F; Nilges M; Ménager H; Sperandio O
Bioinformatics; 2021 Apr; 37(1):89-96. PubMed ID: 33416858
[TBL] [Abstract][Full Text] [Related]
5. Atomic analysis of protein-protein interfaces with known inhibitors: the 2P2I database.
Bourgeas R; Basse MJ; Morelli X; Roche P
PLoS One; 2010 Mar; 5(3):e9598. PubMed ID: 20231898
[TBL] [Abstract][Full Text] [Related]
6. [Chemical libraries dedicated to protein-protein interactions].
Sperandio O; Villoutreix BO; Morelli X; Roche P
Med Sci (Paris); 2015 Mar; 31(3):312-9. PubMed ID: 25855285
[TBL] [Abstract][Full Text] [Related]
7. Exploring the chemical space of protein-protein interaction inhibitors through machine learning.
Choi J; Yun JS; Song H; Kim NH; Kim HS; Yook JI
Sci Rep; 2021 Jun; 11(1):13369. PubMed ID: 34183730
[TBL] [Abstract][Full Text] [Related]
8. The topology of drug-target interaction networks: implicit dependence on drug properties and target families.
Mestres J; Gregori-Puigjané E; Valverde S; Solé RV
Mol Biosyst; 2009 Sep; 5(9):1051-7. PubMed ID: 19668871
[TBL] [Abstract][Full Text] [Related]
9. Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods.
Reynès C; Host H; Camproux AC; Laconde G; Leroux F; Mazars A; Deprez B; Fahraeus R; Villoutreix BO; Sperandio O
PLoS Comput Biol; 2010 Mar; 6(3):e1000695. PubMed ID: 20221258
[TBL] [Abstract][Full Text] [Related]
10. [Network-based local and global consistency of cardiovascular genes].
Zuo X; Lu P; Liu X; Chen J; Gao Y; Yang Y; Yang H
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):130-3. PubMed ID: 22737837
[TBL] [Abstract][Full Text] [Related]
11. Databases of protein-protein interactions and their use in drug discovery.
Fuentes G; Oyarzabal J; Rojas AM
Curr Opin Drug Discov Devel; 2009 May; 12(3):358-66. PubMed ID: 19396737
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
Thiel P; Kaiser M; Ottmann C
Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
[TBL] [Abstract][Full Text] [Related]
13. Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space.
Zhang X; Betzi S; Morelli X; Roche P
Future Med Chem; 2014 Jul; 6(11):1291-307. PubMed ID: 24773599
[TBL] [Abstract][Full Text] [Related]
14. SNAPPI-DB: a database and API of Structures, iNterfaces and Alignments for Protein-Protein Interactions.
Jefferson ER; Walsh TP; Roberts TJ; Barton GJ
Nucleic Acids Res; 2007 Jan; 35(Database issue):D580-9. PubMed ID: 17202171
[TBL] [Abstract][Full Text] [Related]
15. FPPI: Fusarium graminearum protein-protein interaction database.
Zhao XM; Zhang XW; Tang WH; Chen L
J Proteome Res; 2009 Oct; 8(10):4714-21. PubMed ID: 19673500
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Estimate Index for Early-Stage Screening of Compounds Targeting Protein-Protein Interactions.
Kosugi T; Ohue M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681589
[TBL] [Abstract][Full Text] [Related]
17. Protein-protein interactions as new targets for drug design: virtual and experimental approaches.
Ivanov AS; Gnedenko OV; Molnar AA; Mezentsev YV; Lisitsa AV; Archakov AI
J Bioinform Comput Biol; 2007 Apr; 5(2B):579-92. PubMed ID: 17636863
[TBL] [Abstract][Full Text] [Related]
18. In silico carborane docking to proteins and potential drug targets.
Calvaresi M; Zerbetto F
J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
[TBL] [Abstract][Full Text] [Related]
19. Generating Potential Protein-Protein Interaction Inhibitor Molecules Based on Physicochemical Properties.
Ohue M; Kojima Y; Kosugi T
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570623
[TBL] [Abstract][Full Text] [Related]
20. Genome scale enzyme-metabolite and drug-target interaction predictions using the signature molecular descriptor.
Faulon JL; Misra M; Martin S; Sale K; Sapra R
Bioinformatics; 2008 Jan; 24(2):225-33. PubMed ID: 18037612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
